The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of Osteoporosis.

abstract：BACKGROUND:Prescription medication adherence is a known health-related barrier for elderly patients, leading to insufficient disease control and negative health outcomes. The Centers for Medicare & Medicaid Services (CMS) have placed significant emphasis on medication adherence, through the Part D star measures, revolv...

journal_title：Journal of managed care & specialty pharmacy

authors： Winters A,Esse T,Bhansali A,Serna O,Mhatre S,Sansgiry S

更新日期：2016-03-01 00:00:00

abstract：BACKGROUND:Despite evidence showing the benefits of treatment intensification following an elevated hemoglobin A1c (A1c), clinical inertia, or failure to establish and/or escalate treatment to achieve treatment goals, is a concern among patients diagnosed with type 2 diabetes (T2DM). Clinical inertia may contribute to ...

journal_title：Journal of managed care & specialty pharmacy

authors： Ruiz-Negrón N,Wander C,McAdam-Marx C,Pesa J,Bailey RA,Bellows BK

更新日期：2019-03-01 00:00:00

abstract：BACKGROUND:Medication therapy management (MTM) programs were first introduced as a result of the 2003 Medicare Prescription Drug Improvement and Modernization Act. Since then, the Centers for Medicare & Medicaid Services (CMS) have established minimum requirements for health plans to follow in establishing patient elig...

journal_title：Journal of managed care & specialty pharmacy

authors： Miller DE,Roane TE,Salo JA,Hardin HC

更新日期：2016-07-01 00:00:00

abstract：:Improving medication adherence has been identified as a crucial step towards improving health outcomes for patients with chronic disease and has provided the motivation for many changes in our health care system. Despite the volume of research done on this topic, however, we still lack important basic information abou...

journal_title：Journal of managed care & specialty pharmacy

authors： Seabury SA,Gupta CN,Philipson TJ,Henkhaus LE,PhRMA Medication Adherence Advisory Council.

更新日期：2014-08-01 00:00:00

abstract：DISCLOSURES:The author provides consulting services to the pharmaceutical industry, including manufacturers, health plans, employers, and specialty pharmacies, and is a member of the editorial advisory board of Specialty Pharmacy News. The author reports no financial or other conflicts of interest related to the subjec...

journal_title：Journal of managed care & specialty pharmacy

authors： Rubinstein E

更新日期：2016-08-01 00:00:00

abstract：:Section 3002 of the 21st Century Cures Act, which was signed into law in December 2016, requires the FDA to develop one or more sets of new guidances regarding the collection of patient experience data. To explore how patient-reported outcomes (PROs) can support value-based care and discuss challenges to using PROs mo...

journal_title：Journal of managed care & specialty pharmacy

authors：

更新日期：2019-03-21 00:00:00

abstract：:The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potentia...

journal_title：Journal of managed care & specialty pharmacy

authors： Shuman AG,Fox ER,Unguru Y

更新日期：2020-08-01 00:00:00

abstract：BACKGROUND:Diabetes mellitus is associated with substantial morbidity and mortality. With the rise in prevalence of diabetes, there has been an increased need for clinical pharmacy services focused on diabetes management in ambulatory clinics. However, more data IS needed to determine the overall impact that clinical p...

journal_title：Journal of managed care & specialty pharmacy

authors： Chung N,Rascati K,Lopez D,Jokerst J,Garza A

更新日期：2014-09-01 00:00:00

abstract：BACKGROUND:Adjuvant trastuzumab treatment is administered to early stage breast cancer patients in physician office (POV) or hospital outpatient (HOP) settings. OBJECTIVE:To identify treatment patterns, utilization, and costs by site of care (POV vs. HOP) of patients with adjuvant treatment of breast cancer with trast...

journal_title：Journal of managed care & specialty pharmacy

authors： Parthan A,Santos E,Becker L,Small A,Lalla D,Brammer M,Teitelbaum A

更新日期：2014-05-01 00:00:00

abstract：:In a study published last year in the October 2014 issue of the Journal of Managed Care Specialty Pharmacy, Trivedi et al. compared treatment patterns of dasatinib and nilotinib as second-line tyrosine kinase inhibitors (TKI) therapy in chronic myeloid leukemia (CML) patients during the first year of treatment.1 Trive...

journal_title：Journal of managed care & specialty pharmacy

authors： Chen L,Wu EQ

更新日期：2015-11-01 00:00:00

abstract：BACKGROUND:The introduction of anti-vascular endothelial growth factor (anti-VEGF) drugs to ophthalmology has revolutionized the treatment of neovascular age-related macular degeneration (nAMD). Despite this significant progress, gaps and challenges persist in the diagnosis of nAMD, initiation of treatment, and managem...

journal_title：Journal of managed care & specialty pharmacy

authors： Wykoff CC,Clark WL,Nielsen JS,Brill JV,Greene LS,Heggen CL

更新日期：2018-02-01 00:00:00

abstract：BACKGROUND:Optimized medication use involves the effective use of medications for better outcomes, improved patient experience, and lower costs. Few studies systematically gather data on the actions accountable care organizations (ACOs) have taken to optimize medication use. OBJECTIVES:To (a) assess how ACOs optimize ...

journal_title：Journal of managed care & specialty pharmacy

authors： Wilks C,Krisle E,Westrich K,Lunner K,Muhlestein D,Dubois R

更新日期：2017-10-01 00:00:00

abstract：BACKGROUND:Psoriatic arthritis (PsA) is associated with multiple comorbid conditions, including cardiovascular (CV) comorbidities that impose a considerable burden on patients. Effective management of PsA requires an understanding of comorbidity profiles. OBJECTIVE:To compare the frequency and incidence rates of comor...

journal_title：Journal of managed care & specialty pharmacy

authors： Kaine J,Song X,Kim G,Hur P,Palmer JB

更新日期：2019-01-01 00:00:00

abstract：BACKGROUND:Prostacyclins play an important role in the management of pulmonary arterial hypertension (PAH). Intravenous prostacyclin was the first disease-specific treatment for patients with PAH. Subcutaneous and nonparenteral (oral or inhaled) formulations have subsequently become available. However, data are lacking...

journal_title：Journal of managed care & specialty pharmacy

authors： Burger CD,Pruett JA,Lickert CA,Berger A,Murphy B,Drake W 3rd

更新日期：2018-03-01 00:00:00

abstract：BACKGROUND:Tyrosine kinase inhibitors (TKIs) are a mainstay of treatment for patients suffering from chronic myeloid leukemia (CML). Testing for various mutations in the BCR-ABL gene may help predict lack of response to specific TKIs where resistance has developed. OBJECTIVE:To estimate the emergence of BCR-ABL kinase...

journal_title：Journal of managed care & specialty pharmacy

authors： Ursan ID,Jiang R,Pickard EM,Lee TA,Ng D,Pickard AS

更新日期：2015-02-01 00:00:00

abstract：BACKGROUND:Persistence with multiple daily insulin injections (MDI) may be challenging for patients with type 2 diabetes (T2DM). However, limited information is available regarding the effect of persistence with MDI on outcomes. OBJECTIVE:To evaluate persistence with basal and bolus insulin therapy and assess its rela...

journal_title：Journal of managed care & specialty pharmacy

authors： Edelman SV,Ermakova A,Xiong Y,Sieradzan R,Taylor SD

更新日期：2019-12-01 00:00:00

abstract：BACKGROUND:Recent clinical trials indicate that pharmacogenetic-guided treatment of major depressive disorder (MDD) results in higher treatment response rates by genetically matching patients to medications and avoiding a trial-and-error process. OBJECTIVE:To evaluate the cost-effectiveness of a pharmacogenetic test (...

journal_title：Journal of managed care & specialty pharmacy

authors： Groessl EJ,Tally SR,Hillery N,Maciel A,Garces JA

更新日期：2018-08-01 00:00:00

abstract：BACKGROUND:The federal 340B Drug Discount Program provides access to significant drug price discounts for health care organizations in the United States that serve a disproportional share of disadvantaged patients. OBJECTIVE:To analyze trends over a 10-year period (2006~2016) in the price of specialty drugs, contrasti...

journal_title：Journal of managed care & specialty pharmacy

authors： Lee CH,Chang J,McCombs J

更新日期：2019-02-01 00:00:00

abstract：BACKGROUND:The Biologics Price Competition and Innovation Act, introduced as part of the Affordable Care Act, directed the FDA to create an approval pathway for biologic products shown to be biosimilar or interchangeable with an FDA-approved innovator drug. These biosimilars will not be chemically identical to the refe...

journal_title：Journal of managed care & specialty pharmacy

authors： AMCP Task Force on Biosimilar Collective Intelligence Systems.,Baldziki M,Brown J,Chan H,Cheetham TC,Conn T,Daniel GW,Hendrickson M,Hilbrich L,Johnson A,Miller SB,Moore T,Motheral B,Priddy SA,Raebel MA,Randhawa G,Surratt

更新日期：2015-01-01 00:00:00

abstract：BACKGROUND:The impact of formulary management strategies on utilization and expenditures in overactive bladder (OAB) treatment has not been extensively investigated. In 2013, step therapy (ST) policies for 2 branded OAB treatments, mirabegron and fesoterodine, were removed from Humana Medicare Advantage Prescription Dr...

journal_title：Journal of managed care & specialty pharmacy

authors： Abbass IM,Caplan EO,Ng DB,Kristy R,Schermer CR,Bradt P,Collins JM,Chan WM,Suehs BT

更新日期：2017-01-01 00:00:00

abstract：BACKGROUND:Cancer is a major cause of mortality and a major contributor to health care costs in the United States. An increasing number of cancer patients are treated with oral cancer therapy. Older patients are more likely to have cancer and to be at risk for adherence problems with oral cancer drugs. As a result of s...

journal_title：Journal of managed care & specialty pharmacy

authors： Kaisaeng N,Harpe SE,Carroll NV

更新日期：2014-07-01 00:00:00

abstract：BACKGROUND:Individuals with Down syndrome (DS) experience various comorbidities in excess of the prevalence seen among the non-DS population. However, the extent of the excess burden of comorbidities specifically within commercially and publicly insured DS populations aged < 21 years is not currently known. OBJECTIVES...

journal_title：Journal of managed care & specialty pharmacy

authors： Kong AM,Hurley D,Evans KA,Brixner D,Csoboth C,Visootsak J

更新日期：2017-07-01 00:00:00

abstract：BACKGROUND:In recent years, there have been a number of pharmacological innovations for Crohn's disease (CD), a difficult-to-treat condition, including new treatment philosophies (e.g., top-down therapy) and new therapeutic options in terms of the agent and the route of administration. Three anti-tumor necrosis factor ...

journal_title：Journal of managed care & specialty pharmacy

authors： Liu J,Sylwestrzak G,Ruggieri AP,DeVries A

更新日期：2015-07-01 00:00:00

abstract：BACKGROUND:Discarding unused drugs after dose changes or discontinuation can significantly affect pharmacy budgets. This is especially concerning for expensive oncology agents. However, few economic studies account for drug wastage, providing an inaccurate estimate of a drug's actual economic cost, cost-effectiveness, ...

journal_title：Journal of managed care & specialty pharmacy

authors： Biskupiak J,Oderda G,Brixner D,Tang D,Zacker C,Dalal AA

更新日期：2019-08-01 00:00:00

abstract：:The AMCP Abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice through publication in AMCP's Journal of Managed Care & Specialty Pharmacy (JMCP). Most of the reviewed and unreviewed abstracts are presented as posters so that interested AMCP mee...

journal_title：Journal of managed care & specialty pharmacy

authors：

更新日期：2016-04-01 00:00:00

abstract：:A panel of experts drawn from neurology, psychiatry, geropsychiatry, geriatrics, and pharmacy representatives of 3 health plans convened in New York City on July 30, 2016, with the objective of sharing opinions, ideas, and information regarding the optimal management of Parkinson's disease psychosis (PDP). Three key p...

journal_title：Journal of managed care & specialty pharmacy

authors： Hermanowicz N,Alva G,Pagan F,Espay AJ,Patel A,Madrid KC,Kremens D,Kenney J,Arquette S,Tereso G,Lopes M,Farnum C

更新日期：2017-06-01 00:00:00

abstract：BACKGROUND:In 2013, it was reported that about 1 of every 3 U.S. adults has hypertension. Of these 70 million individuals, approximately 50% have their blood pressure under control. Achieving hypertension control, especially in at-risk populations, requires a multipronged approach that includes lifestyle modifications ...

journal_title：Journal of managed care & specialty pharmacy

authors： Lustig A,Ogden M,Brenner RW,Penso J,Westrich KD,Dubois RW

更新日期：2016-10-01 00:00:00

abstract：BACKGROUND:Value-based insurance design (VBID) waives or reduces prescription copayments in order to decrease member cost barriers to refilling medications. Medication therapy management (MTM) is a member clinical intervention designed to reinforce members' knowledge of their medications, which addresses barriers to me...

journal_title：Journal of managed care & specialty pharmacy

authors： Peaslee A,Wickizer M,Olson J,Topp R

更新日期：2016-11-01 00:00:00

abstract：BACKGROUND:Despite multiple treatment options, the prognosis of pulmonary arterial hypertension (PAH) remains poor. PAH patients experience a high economic burden due to comorbidities, hospitalizations, and medication costs. Although combination therapy has been shown to reduce hospitalizations, the relationship betwee...

journal_title：Journal of managed care & specialty pharmacy

authors： Burger CD,Ozbay AB,Lazarus HM,Riehle E,Montejano LB,Lenhart G,White RJ

更新日期：2018-08-01 00:00:00

abstract：DISCLOSURES:Funding for this summary was contributed by the Laura and John Arnold Foundation and California Health Care Foundation to the Institute for Clinical and Economic Review (ICER), an independent organization that evaluates the evidence on the value of health care interventions. ICER's annual policy summit is s...

journal_title：Journal of managed care & specialty pharmacy

authors： Pearson SD,Thokala P,Stevenson M,Rind D

更新日期：2019-12-01 00:00:00